The Traderszone Network

Published in TZ Latest News 3 April, 2016 by The TZ Newswire Staff

Patent Palooza: One Patent Battle in Hep C, And Another Patent Brawl Brewing On Capitol Hill

Merck, Gilead Sciences, and Ionis get a verdict in their patent suit, and Congress calls for a patent review of Medivation’s Xtandi.